Siti Nadia Tarmizi, a spokesperson for Indonesia's COVID-19 vaccine program, said the World Health Organization had found the Chinese vaccines had met requirements by being more than 50% effective. She noted that clinical trials for the Sinovac vaccine in Indonesia showed it was 65% effective.
Tarmizi said Indonesia would wait to see the results of any clinical trials before considering mixing vaccines. China currently has five vaccines in use in its mass immunization campaign, three inactivated-virus vaccines from Sinovac and Sinopharm, a one-shot vaccine from CanSino, and the last from Gao's team in partnership with Anhui Zhifei Longcom.
As of April 2, some 34 million people in China have received the full two doses of Chinese vaccines and about 65 million received one, according to Gao.
Source: Healthcare Press (healthcarepress.net)